COMMONWEALTH OF AUSTRALIA

Instrument number PB 42 of 2008

Amendment determinations under sections 85, 85A and 88 of the National Health Act 1953

I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under sections 85, 85A and 88 of the National Health Act 1953.

Dated  Second of April   2008

 

DIANA MACDONELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

 

Amendment determination — pharmaceutical benefits

1 Commencement

  This instrument commences on 1 May 2008.

2 Amendment of PB 89 of 2007

  Schedule 1 amends PB 89 of 2007.

Schedule 1 Amendments

 

[1]               Part 1 of Schedule 1, item dealing with Amlodipine in the form Tablet 5 mg (as besylate)

in the column headed “Brand” insert in alphabetical order:

 

 Amlodipine-GA

[2]               Part 1 of Schedule 1, item dealing with Amlodipine in the form Tablet 10 mg (as besylate)

in the column headed “Brand” insert in alphabetical order:

 

 Amlodipine-GA

[3]               Part 1 of Schedule 1, item dealing with Amoxycillin in the form Tablet 1 g (as trihydrate)

omit from the column headed “Brand”:

 

 Amoxil Duo

[4]               Part 1 of Schedule 1, item dealing with Flucloxacillin in the form Capsule 250 mg (as sodium)

omit from the column headed “Brand”:

 

 Floxapen

 

[5]               Part 1 of Schedule 1, item dealing with Flucloxacillin in the form Capsule 500 mg (as sodium)

omit from the column headed “Brand”:

 

 Floxapen

[6]               Part 1 of Schedule 1, after item dealing with Flucloxacillin in the form Powder for oral suspension 125 mg
(as magnesium) per 5 mL, 100 mL

insert in the columns in the order indicated:

 

 

Powder for oral liquid 125 mg (as sodium) per 5 mL, 100 mL

Oral

1

..

Aspen Pharmacare Australia Pty Limited

[7]               Part 1 of Schedule 1, after item dealing with Flucloxacillin in the form Powder for oral suspension 250 mg
(as magnesium) per 5 mL, 100 mL

insert in the columns in the order indicated:

 

 

Powder for oral liquid 250 mg (as sodium) per 5 mL, 100 mL

Oral

1

..

Aspen Pharmacare Australia Pty Limited

 

[8]               Part 1 of Schedule 1, item dealing with Gabapentin in the form Tablet 600 mg

 

in the column headed “Brand” insert in alphabetical order:

 

 Pharmacor Gabapentin 600

[9]               Part 1 of Schedule 1, item dealing with Gabapentin in the form Tablet 800 mg

 

in the column headed “Brand” insert in alphabetical order:

 

 Pharmacor Gabapentin 800

[10]          Part 1 of Schedule 1, item dealing with Isosorbide Dinitrate in the form Tablet 10 mg

omit from the column headed “Brand”:

 

 Isordil

    

 

[11]          Part 1 of Schedule 1, item dealing with Lamotrigine in the form Tablet 25 mg

 

in the column headed “Brand” insert in alphabetical order:

 

 Lamotrigine generichealth

 

 

[12]          Part 1 of Schedule 1, item dealing with Lamotrigine in the form Tablet 50 mg

 

in the column headed “Brand” insert in alphabetical order:

 

 Lamotrigine generichealth

 

[13]          Part 1 of Schedule 1, item dealing with Lamotrigine in the form Tablet 100 mg

 

in the column headed “Brand” insert in alphabetical order:

 

 Lamotrigine generichealth

 

[14]          Part 1 of Schedule 1, item dealing with Lamotrigine in the form Tablet 200 mg

 

in the column headed “Brand” insert in alphabetical order:

 

 Lamotrigine generichealth

[15]          Part 1 of Schedule 1, after items dealing with Lansoprazole

insert in the columns in the order indicated:

 

Lapatinib

Tablet 250 mg (as ditosylate monohydrate)

Oral

140

2

Tykerb

[16]          Part 1 of Schedule 1, after items dealing with Lercanidipine

insert in the columns in the order indicated:

 

Lercanidipine with enalapril

Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 10 mg

Oral

30

5

Zan-Extra 10/10

 

Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 20 mg

Oral

30

5

Zan-Extra 10/20

[17]          Part 1 of Schedule 1, item dealing with Lisinopril in the form Tablet 20 mg

in the column headed “Brand” insert in alphabetical order:

  

  Lisinopril generichealth

[18]          item dealing with Macrogol 3350

insert as the first entry in the columns in the order indicated:

 

 

Sachets containing powder for oral solution 6.563 g with electrolytes, 30

Oral

1

5

Movicol-Half

[19]          Part 1 of Schedule 1, after item dealing with Risedronic Acid and Calcium

insert in the columns in the order indicated:

 

Risedronic acid and calcium with colecalciferol

Pack containing 4 tablets risedronate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g with colecalciferol 22 micrograms

Oral

1

5

Actonel Combi D

[20]          Part 1 of Schedule 1, item dealing with Salmeterol

omit from the columns in the order indicated:

 

 

Pressurised inhalation 25 micrograms (as xinafoate) per dose, 120 doses

Inhalation by mouth

1

5

Serevent

 


[21]          Part 1 of Schedule 1, item dealing with Sertraline in the form Tablet 50 mg (as hydrochloride)

in the column headed “Brand” insert in alphabetical order:

  

  Sertra 50

[22]          Part 1 of Schedule 1, item dealing with Sertraline in the form Tablet 100 mg (as hydrochloride)

in the column headed “Brand” insert in alphabetical order:

  

  Sertra 100

[23]          Part 1 of Schedule 1, item dealing with Tramadol in the form Tablet containing tramadol hydrochloride 100 mg (sustained release)

in the column headed “Brand” insert in alphabetical order:

  

  Tramedo SR 100

[24]          Part 1 of Schedule 1, item dealing with Tramadol in the form Tablet containing tramadol hydrochloride 150 mg (sustained release)

in the column headed “Brand” insert in alphabetical order:

  

  Tramedo SR 150


[25]          Part 1 of Schedule 1, item dealing with Tramadol in the form Tablet containing tramadol hydrochloride 200 mg (sustained release)

in the column headed “Brand” insert in alphabetical order:

  

  Tramedo SR 200

[26]          Part 2 of Schedule 1, item dealing with Tramadol in the form Tablet containing tramadol hydrochloride 100 mg (sustained release)

in the column headed “Brand” insert in alphabetical order:

  

  Tramedo SR 100

[27]          Part 2 of Schedule 1, item dealing with Tramadol in the form Tablet containing tramadol hydrochloride 150 mg (sustained release)

in the column headed “Brand” insert in alphabetical order:

  

  Tramedo SR 150

[28]          Part 2 of Schedule 1, item dealing with Tramadol in the form Tablet containing tramadol hydrochloride 200 mg (sustained release)

in the column headed “Brand” insert in alphabetical order:

  

  Tramedo SR 200

[29]          Part 1 of Schedule 3, item dealing with Flucloxacillin in the form Capsule 250 mg (as sodium)

omit from the column headed “Brand”:

 

 Floxapen

[30]          Part 1 of Schedule 3, item dealing with Flucloxacillin in the form Capsule 500 mg (as sodium)

omit from the column headed “Brand”:

 

 Floxapen

[31]          Part 1 of Schedule 3, after item dealing with Flucloxacillin in the form Powder for oral suspension 125 mg (as magnesium) per 5 mL, 100 mL

insert in the columns in the order indicated:

 

 

Powder for oral liquid 125 mg (as sodium) per 5 mL, 100 mL

Oral

1

..

Aspen Pharmacare Australia Pty Limited

[32]          Part 1 of Schedule 3, after item dealing with Flucloxacillin in the form Powder for oral suspension 250 mg (as magnesium) per 5 mL, 100 mL

insert in the columns in the order indicated:

 

 

Powder for oral liquid 250 mg (as sodium) per 5 mL, 100 mL

Oral

1

..

Aspen Pharmacare Australia Pty Limited

 


[33]          Part 1 of Schedule 3, item dealing with Tramadol in the form Tablet containing tramadol hydrochloride 100 mg (sustained release)

in the column headed “Brand” insert in alphabetical order:

  

  Tramedo SR 100

[34]          Part 1 of Schedule 3, item dealing with Tramadol in the form Tablet containing tramadol hydrochloride 150 mg (sustained release)

in the column headed “Brand” insert in alphabetical order:

  

  Tramedo SR 150

[35]          Part 1 of Schedule 3, item dealing with Tramadol in the form Tablet containing tramadol hydrochloride 200 mg (sustained release)

in the column headed “Brand” insert in alphabetical order:

  

  Tramedo SR 200